{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:03:02Z","timestamp":1787065382365,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["23S41900200"],"award-info":[{"award-number":["23S41900200"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["23J21900600"],"award-info":[{"award-number":["23J21900600"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373269"],"award-info":[{"award-number":["82373269"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008750","name":"Shanghai Shenkang Hospital Development Center","doi-asserted-by":"publisher","award":["SHDC12021113"],"award-info":[{"award-number":["SHDC12021113"]}],"id":[{"id":"10.13039\/501100008750","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.phymed.2026.158179","type":"journal-article","created":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T22:21:14Z","timestamp":1776637274000},"page":"158179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Nanocrystalline berberine is associated with improved antitumor activity of PD-1 blockade in ovarian cancer"],"prefix":"10.1016","volume":"156","author":[{"given":"Yujie","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9342-9747","authenticated-orcid":false,"given":"Jiajun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guihai","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6026-6712","authenticated-orcid":false,"given":"Zhongping","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.phymed.2026.158179_bib0001","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12967-022-03405-8","article-title":"Patient-derived xenograft (PDX) models, applications and challenges in cancer research","volume":"20","author":"Abdolahi","year":"2022","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.phymed.2026.158179_bib0002","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13045-019-0779-5","article-title":"Immune checkpoint inhibitors of PD-L1 as cancer therapeutics","volume":"12","author":"Akinleye","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"10","key":"10.1016\/j.phymed.2026.158179_bib0003","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.ccell.2024.08.016","article-title":"Ovarian cancer metastasis: looking beyond the surface","volume":"42","author":"Bayraktar","year":"2024","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.phymed.2026.158179_bib0004","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/ijc.34002","article-title":"Ovarian cancer today and tomorrow: a global assessment by world region and human development index using GLOBOCAN 2020","volume":"151","author":"Cabasag","year":"2022","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.phymed.2026.158179_bib0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20030642","article-title":"Cyclodextrin(-)drug inclusion complexes: in vivo and in vitro approaches","volume":"20","author":"Carneiro","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2026.158179_bib0006","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","article-title":"Profiling tumor infiltrating immune cells with CIBERSORT","volume":"1711","author":"Chen","year":"2018","journal-title":"Methods Mol. Biol."},{"issue":"5","key":"10.1016\/j.phymed.2026.158179_bib0008","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/tox.23076","article-title":"Dual down-regulation of EGFR and ErbB2 by berberine contributes to suppression of migration and invasion of human ovarian cancer cells","volume":"36","author":"Chuang","year":"2021","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.phymed.2026.158179_bib0009","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-3-319-41334-1_2","article-title":"Berberine and its role in chronic disease","volume":"928","author":"Cicero","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1","key":"10.1016\/j.phymed.2026.158179_bib0010","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/bjc.2014.555","article-title":"PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients","volume":"112","author":"D'incecco","year":"2015","journal-title":"Br. J. Cancer"},{"issue":"1\u20132","key":"10.1016\/j.phymed.2026.158179_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2006.07.011","article-title":"A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system","volume":"321","author":"Dokoumetzidis","year":"2006","journal-title":"Int. J. Pharm."},{"issue":"23","key":"10.1016\/j.phymed.2026.158179_bib0012","doi-asserted-by":"crossref","first-page":"6900","DOI":"10.1158\/0008-5472.CAN-13-1550","article-title":"Therapeutic PD-1 pathway blockade augments with other modalities of immunotherapy T-cell function to prevent immune decline in ovarian cancer","volume":"73","author":"Duraiswamy","year":"2013","journal-title":"Cancer Res."},{"issue":"23","key":"10.1016\/j.phymed.2026.158179_bib0013","doi-asserted-by":"crossref","first-page":"13573","DOI":"10.1111\/jcmm.16049","article-title":"Anti-inflammatory and immune-modulatory impacts of berberine on activation of autoreactive T cells in autoimmune inflammation","volume":"24","author":"Ehteshamfar","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.phymed.2026.158179_bib0014","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.powtec.2014.01.095","article-title":"Ostwald\u2013Freundlich diffusion-limited dissolution kinetics of nanoparticles","volume":"257","author":"Ely","year":"2014","journal-title":"Powder Technol."},{"issue":"1","key":"10.1016\/j.phymed.2026.158179_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009220","article-title":"Interferon regulatory factor 1 (IRF1) and anti-pathogen innate immune responses","volume":"17","author":"Feng","year":"2021","journal-title":"PLoS Pathog."},{"issue":"7","key":"10.1016\/j.phymed.2026.158179_bib0016","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.7150\/thno.30787","article-title":"Berberine in cardiovascular and metabolic diseases: from mechanisms to therapeutics","volume":"9","author":"Feng","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.phymed.2026.158179_bib0017","series-title":"Seminars in Oncology","first-page":"258","article-title":"Cancer prevention with natural compounds","author":"Gullett","year":"2010"},{"issue":"3","key":"10.1016\/j.phymed.2026.158179_bib0018","first-page":"727","article-title":"PD-1\/PD-L1 pathway: current researches in cancer","volume":"10","author":"Han","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.phymed.2026.158179_bib0019","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.colsurfb.2012.08.017","article-title":"Dissolution process analysis using model-free Noyes\u2013Whitney integral equation","volume":"102","author":"Hattori","year":"2013","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.phymed.2026.158179_bib0020","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/B978-0-12-816505-8.00007-2","article-title":"Multifunctional nanocrystals for cancer therapy: a potential nanocarrier","author":"Joseph","year":"2019","journal-title":"Nanomater. Drug Deliv. Ther."},{"key":"10.1016\/j.phymed.2026.158179_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117346","article-title":"Berberine induces dose-dependent quiescence and apoptosis in A549 cancer cells by modulating cell cyclins and inflammation independent of mTOR pathway","volume":"244","author":"Kumar","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.phymed.2026.158179_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113678","article-title":"IRF1 transcriptionally up-regulates CXCL10 which increases CD8(+) T cells infiltration in colorectal cancer","volume":"144","author":"Li","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phymed.2026.158179_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40659-019-0243-6","article-title":"Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells","volume":"52","author":"Liu","year":"2019","journal-title":"Biol. Res."},{"issue":"16","key":"10.1016\/j.phymed.2026.158179_bib0024","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.2217\/nnm.15.73","article-title":"Developing nanocrystals for cancer treatment","volume":"10","author":"Lu","year":"2015","journal-title":"Nanomedicine"},{"issue":"4","key":"10.1016\/j.phymed.2026.158179_bib0025","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.clinthera.2015.02.018","article-title":"The next immune-checkpoint inhibitors: PD-1\/PD-L1 blockade in melanoma","volume":"37","author":"Mahoney","year":"2015","journal-title":"Clin. Ther."},{"issue":"2","key":"10.1016\/j.phymed.2026.158179_bib0026","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ctrv.2014.12.013","article-title":"PD-1 blockade therapy in renal cell carcinoma: current studies and future promises","volume":"41","author":"Massari","year":"2015","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.phymed.2026.158179_bib0027","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.pharmthera.2018.01.003","article-title":"Combining chemotherapy with PD-1 blockade in NSCLC","volume":"186","author":"Mathew","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phymed.2026.158179_bib0028","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.61","article-title":"Ovarian cancer","volume":"2","author":"Matulonis","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"4","key":"10.1016\/j.phymed.2026.158179_bib0029","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1634\/theoncologist.2016-0419","article-title":"Safety and tolerability of PD-1\/PD-L1 inhibitors compared with chemotherapy in patients with advanced cancer: a meta-analysis","volume":"22","author":"Nishijima","year":"2017","journal-title":"Oncologist"},{"issue":"6","key":"10.1016\/j.phymed.2026.158179_bib0030","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.phrs.2009.01.017","article-title":"Natural compounds for cancer treatment and prevention","volume":"59","author":"Nobili","year":"2009","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.phymed.2026.158179_bib0031","first-page":"561","article-title":"Ovarian cancer: an overview","volume":"91","author":"Penny","year":"2020","journal-title":"Radiol. Technol."},{"issue":"8054","key":"10.1016\/j.phymed.2026.158179_bib0032","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/s41586-024-08466-x","article-title":"Tissue-resident memory CD8 T cell diversity is spatiotemporally imprinted","volume":"639","author":"Reina-Campos","year":"2025","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.phymed.2026.158179_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2017.08.027","article-title":"Oncolytic virotherapy promotes intratumoral T cell infiltration and improves anti-PD-1 immunotherapy","volume":"170","author":"Ribas","year":"2017","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.phymed.2026.158179_bib0034","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/carcin\/21.4.585","article-title":"Development of a syngeneic mouse model for events related to ovarian cancer","volume":"21","author":"Roby","year":"2000","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.phymed.2026.158179_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-024-54565-8","article-title":"Integrative multi-omics analysis uncovers tumor-immune-gut axis influencing immunotherapy outcomes in ovarian cancer","volume":"15","author":"Rosario","year":"2024","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.phymed.2026.158179_bib0036","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1080\/01635581.2019.1595049","article-title":"Dietary fat intake and risk of ovarian cancer: a systematic review and dose-response meta-analysis of observational studies","volume":"71","author":"Sadeghi","year":"2019","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.phymed.2026.158179_bib0037","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.addr.2020.07.002","article-title":"Liposomes: advancements and innovation in the manufacturing process","volume":"154-155","author":"Shah","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"626","key":"10.1016\/j.phymed.2026.158179_bib0038","doi-asserted-by":"crossref","first-page":"eabf0992","DOI":"10.1126\/scitranslmed.abf0992","article-title":"TRIB3 reduces CD8(+) T cell infiltration and induces immune evasion by repressing the STAT1-CXCL10 axis in colorectal cancer","volume":"14","author":"Shang","year":"2022","journal-title":"Sci. Transl. Med."},{"issue":"7941","key":"10.1016\/j.phymed.2026.158179_bib0039","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s41586-022-05496-1","article-title":"Ovarian cancer mutational processes drive site-specific immune evasion","volume":"612","author":"V\u00e1zquez-Garc\u00eda","year":"2022","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.phymed.2026.158179_bib0040","first-page":"41","article-title":"Solubility enhancement techniques","volume":"5","author":"Vemula","year":"2010","journal-title":"Int. J. Pharm. Sci. Rev. Res."},{"issue":"1","key":"10.1016\/j.phymed.2026.158179_bib0041","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1158\/0008-5472.CAN-20-1674","article-title":"Enhanced efficacy of simultaneous PD-1 and PD-L1 immune checkpoint blockade in high-grade serous ovarian cancer","volume":"81","author":"Wan","year":"2021","journal-title":"Cancer Res."},{"issue":"46","key":"10.1016\/j.phymed.2026.158179_bib0042","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.12589","article-title":"Berberine inhibits EGFR signaling and enhances the antitumor effects of EGFR inhibitors in gastric cancer","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.phymed.2026.158179_bib0043","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1124\/pr.112.005660","article-title":"Strategies to address low drug solubility in discovery and development","volume":"65","author":"Williams","year":"2013","journal-title":"Pharmacol. Rev."},{"issue":"48","key":"10.1016\/j.phymed.2026.158179_bib0044","doi-asserted-by":"crossref","first-page":"eads3596","DOI":"10.1126\/sciadv.ads3596","article-title":"Convergent evolution of berberine biosynthesis","volume":"10","author":"Xu","year":"2024","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.phymed.2026.158179_bib0045","doi-asserted-by":"crossref","first-page":"464","DOI":"10.7150\/thno.22711","article-title":"Recent advances in the application of vitamin E TPGS for drug delivery","volume":"8","author":"Yang","year":"2018","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.phymed.2026.158179_bib0046","first-page":"2603","article-title":"Berberine induces lipolysis in porcine adipocytes by activating the AMP\u2011activated protein kinase pathway","volume":"21","author":"Yang","year":"2020","journal-title":"Mol. Med. Rep."},{"issue":"9","key":"10.1016\/j.phymed.2026.158179_bib0047","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1080\/15384047.2016.1210728","article-title":"Berberine reverses lapatinib resistance of HER2-positive breast cancer cells by increasing the level of ROS","volume":"17","author":"Zhang","year":"2016","journal-title":"Cancer Biol. Ther."},{"issue":"13","key":"10.1016\/j.phymed.2026.158179_bib0048","article-title":"Impact of surgical compliance on survival prognosis of patients with ovarian cancer and associated influencing factors: a propensity score matching analysis of the SEER database","volume":"10","author":"Zhang","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.phymed.2026.158179_bib0049","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1002\/sctm.21-0083","article-title":"Development and investigational new drug application of mesenchymal stem\/stromal cells products in China","volume":"10","author":"Zhao","year":"2021","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.phymed.2026.158179_bib0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1083788","article-title":"Berberine a traditional Chinese drug repurposing: its actions in inflammation-associated ulcerative colitis and cancer therapy","volume":"13","author":"Zhu","year":"2022","journal-title":"Front. Immunol."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326004137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326004137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T15:19:16Z","timestamp":1780067956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711326004137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":49,"alternative-id":["S0944711326004137"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158179","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanocrystalline berberine is associated with improved antitumor activity of PD-1 blockade in ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158179","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"158179"}}